| 9941-6 |
Q wave duration.lead II |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave duration in lead II |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
9941-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave dur L-II |
|
|
|
Y |
|
2; Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave dur L-II; QNT; Quan; Quant; Quantitative; Q-wave interval; Random |
2.48 |
1.0i |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 99410-3 |
Cupressus sempervirens Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Italian Cypress IgG Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99410-3 |
|
|
|
|
Both |
|
|
|
0 |
Italian Cypress IgG-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Funeral cypress; Immune globulin G; Immunoglobulin G; Italian cypress; Level; Mass concentration; Mediterranean cypress; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t023; t23 |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99411-1 |
Voltage-gated calcium channel Ab |
SCnc |
CSF |
Pt |
Qn |
IA |
|
ACTIVE |
Voltage-gated calcium channel Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
SERO |
|
99411-1 |
|
IA |
|
|
Both |
|
|
|
0 |
VGCC Ab CSF IA-sCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ca; Cal; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lamblia intestinalis; LEMS; Level; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCCA; Voltage-dependent calcium channels |
2.72 |
2.72 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 99412-9 |
Beta globulin |
MCnc |
Ser/Plas |
Pt |
Qn |
Immunofixation |
|
ACTIVE |
Beta globulin [Mass/volume] in Serum or Plasma by Immunofixation |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
99412-9 |
|
Immunofixation |
|
|
Both |
|
|
|
0 |
B-Globulin SerPl IFE-mCnc |
|
|
|
N |
|
B; B-Globulin; Chemistry; GLB; Glob; Glob%; Globul; Globulins; IFE; Ifix; Immunofixation electrophoresis; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 99413-7 |
cycloSPORINE |
TmMCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
cycloSPORINE [AUC] in Blood |
|
ADD |
DefinitionDescription |
|
|
ug*h/L |
|
|
|
|
|
|
DRUG/TOX |
|
99413-7 |
|
|
|
|
Both |
|
|
|
0 |
cycloSPORINE Bld-AUC |
|
|
|
N |
|
AUC; Blood; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; Gengraf; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; WB; Whole blood |
2.72 |
2.72 |
|
|
|
|
|
|
|
ug.h/L |
|
|
|
0 |
| 99414-5 |
Gamma globulin |
MCnc |
Ser/Plas |
Pt |
Qn |
Immunofixation |
|
ACTIVE |
Gamma globulin [Mass/volume] in Serum or Plasma by Immunofixation |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
99414-5 |
|
Immunofixation |
|
|
Both |
|
|
|
0 |
Gamma glob SerPl IFE-mCnc |
|
|
|
N |
|
Chemistry; GLB; Glob; Glob%; Globul; Globulins; IFE; Ifix; Immunofixation electrophoresis; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 99415-2 |
Protein.monoclonal band 1 |
MCnc |
Ser/Plas |
Pt |
Qn |
Immunofixation |
|
ACTIVE |
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Immunofixation |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
99415-2 |
|
Immunofixation |
|
|
Both |
|
|
|
0 |
M Protein 1 SerPl IFE-mCnc |
|
|
|
N |
|
Bands; bnd; Chemistry; i; IFE; Ifix; Immunofixation electrophoresis; Level; M Protein; M Protein 1; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 99416-0 |
Protein.monoclonal band 2 |
MCnc |
Ser/Plas |
Pt |
Qn |
Immunofixation |
|
ACTIVE |
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Immunofixation |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
99416-0 |
|
Immunofixation |
|
|
Both |
|
|
|
0 |
M Protein 2 SerPl IFE-mCnc |
|
|
|
N |
|
Bands; bnd; Chemistry; IFE; Ifix; II; Immunofixation electrophoresis; Level; M Protein; M Protein 2; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 99417-8 |
Shared decision making panel |
- |
^Patient |
Pt |
- |
R-Outcomes |
|
ACTIVE |
Shared decision making panel [R-Outcomes] |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright �© 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission |
|
|
|
|
PANEL.SURVEY.R-OUTCOMES |
|
99417-8 |
|
R-Outcomes |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Decision-making; Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES |
2.72 |
2.72 |
|
Panel |
|
|
Copyright �© 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission |
|
|
|
|
|
|
0 |
| 99418-6 |
Shared decision making total score |
Score |
^Patient |
Pt |
Qn |
R-Outcomes |
|
ACTIVE |
Shared decision making total score [R-Outcomes] |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright �© 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission |
|
|
|
|
SURVEY.R-OUTCOMES |
|
99418-6 |
|
R-Outcomes |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Decision-making; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES; Tot; Totl |
2.72 |
2.72 |
|
|
|
|
Copyright �© 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission |
|
|
{score} |
|
|
|
0 |
| 99419-4 |
Know possible benefits of treatment plan |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Know possible benefits of treatment plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.R-OUTCOMES |
|
99419-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; Tx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9942-4 |
Q wave duration.lead III |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave duration in lead III |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
9942-4 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave dur L-III |
|
|
|
Y |
|
3; Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave dur L-III; QNT; Quan; Quant; Quantitative; Q-wave interval; Random |
2.48 |
1.0i |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 99420-2 |
Know possible downside of treatment plan |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Know possible downside of treatment plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.R-OUTCOMES |
|
99420-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; Tx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99421-0 |
Know available choices for treatment plan |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Know available choices for treatment plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.R-OUTCOMES |
|
99421-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; Tx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99422-8 |
Feel fully involved in treatment plan |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Feel fully involved in treatment plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.R-OUTCOMES |
|
99422-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; Tx |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 99423-6 |
Time to complete survey |
Time |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Time to complete survey |
|
ADD |
DefinitionDescription |
|
|
min |
|
|
|
|
|
|
SURVEY.PROWL |
|
99423-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Point in time; QNT; Quan; Quant; Quantitative; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
min |
|
|
|
0 |
| 99424-4 |
Penicillin G Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Penicillin G IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99424-4 |
|
|
|
|
Both |
|
|
|
0 |
Penicillin G IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Benzylpenicillin; c1; Level; Mass concentration; PCN; Pen; Penicilloyl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Wycillin |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99425-1 |
Penicillin V Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Penicillin V IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99425-1 |
|
|
|
|
Both |
|
|
|
0 |
Penicillin V IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c2; Level; Mass concentration; PCN; Pen; Penicilloyl; Phenoxymethylpenicillin; Point in time; QNT; Quan; Quant; Quantitative; Random; Rh Blood Group System; Serum; SR; Wycillin |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99426-9 |
Amoxicillin Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Amoxicillin IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99426-9 |
|
|
|
|
Both |
|
|
|
0 |
Amoxicillin IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amox; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bristamox; c204; c6; Larotid; Level; Mass concentration; Moxalin; Point in time; Polymox; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sumox; Trimox; Wymox |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99427-7 |
Blomia tropicalis Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Blomia tropicalis IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99427-7 |
|
|
|
|
Both |
|
|
|
0 |
B tropicalis IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B tropicalis; d201; HDM; House dust mite; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99428-5 |
Dermatophagoides microceras Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Dermatophagoides microceras IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99428-5 |
|
|
|
|
Both |
|
|
|
0 |
D microceras IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D microceras; d3; HDM; House dust mite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99429-3 |
Tyrophagus putrescentiae Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Tyrophagus putrescentiae IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99429-3 |
|
|
|
|
Both |
|
|
|
0 |
T putrescentiae IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d72; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite; T putrescentiae |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 9943-2 |
Q wave duration.lead V1 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave duration in lead V1 |
|
MIN |
DefinitionDescription |
|
|
ms |
|
|
|
|
|
|
EKG.MEAS |
|
9943-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave dur L-V1 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave dur L-V1; QNT; Quan; Quant; Quantitative; Q-wave interval; Random |
2.48 |
1.0i |
|
|
|
|
|
|
|
ms |
|
|
|
0 |
| 99430-1 |
Euroglyphus maynei Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Euroglyphus maynei IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99430-1 |
|
|
|
|
Both |
|
|
|
0 |
E maynei IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d74; E maynei; HDM; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 99431-9 |
Goat epithelium Ab.IgG4 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Goat epithelium IgG4 Ab [Mass/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
ALLERGY |
|
99431-9 |
|
|
|
|
Both |
|
|
|
0 |
Goat Epith IgG4-mCnc |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e80; Epithelia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |